# GIMD1

## Overview
GIMD1 is a gene that encodes the protein GIMAP family P-loop NTPase domain containing 1, which is part of the GIMAP family known for its involvement in immune regulation and apoptosis. This protein is categorized as a P-loop NTPase, a class of enzymes that hydrolyze nucleoside triphosphates and are crucial in various cellular processes. The GIMD1 gene has been studied for its potential role in metabolic disorders, such as type 2 diabetes mellitus, and its expression is influenced by various factors, including treatment with natural extracts and epigenetic modifications (Cho2023Comparative; Cuellar2018Genomewide; Xia2020Hepatic). Understanding the function and regulation of GIMD1 could provide insights into its involvement in complex human traits and diseases.

## Clinical Significance
The GIMD1 gene, part of the GIMAP family, is implicated in various clinical conditions due to its role in immune regulation and apoptosis. Alterations in the expression of GIMD1 have been associated with type 2 diabetes mellitus (T2DM). In Zucker diabetic fatty (ZDF) rats, a model for T2DM, GIMD1 was among the differentially expressed genes, suggesting its involvement in the disease's progression and related metabolic disorders (Xia2020Hepatic). 

In human HaCaT cells, GIMD1 was identified as one of the top downregulated genes following treatment with Gynostemma pentaphyllum extracts, indicating potential clinical significance in gene expression regulation (Cho2023Comparative). This downregulation could imply a role in conditions where gene expression modulation is critical, such as cancer or immune disorders.

Additionally, GIMD1 is associated with a CpG site that displayed significant parent-of-origin effects on DNA methylation, which may have implications for understanding complex human traits and diseases (Cuellar2018Genomewide). These findings suggest that GIMD1 may be involved in the genetic and epigenetic mechanisms underlying various health conditions, although specific diseases directly linked to GIMD1 mutations remain to be fully elucidated.


## References


[1. (Cho2023Comparative) Won Kyong Cho, Seung Hye Paek, Soo-Yun Kim, Sung Joo Jang, Sak Lee, Hoseong Choi, Yeonhwa Jo, Jeong Hun Lee, and Sang Hyun Moh. Comparative transcriptome profiles of human hacat cells in response to gynostemma pentaphyllum extracts obtained using three independent methods by rna sequencing. Life, 13(2):423, February 2023. URL: http://dx.doi.org/10.3390/life13020423, doi:10.3390/life13020423. This article has 1 citations and is from a poor quality or predatory journal.](https://doi.org/10.3390/life13020423)

[2. (Cuellar2018Genomewide) Gabriel Cuellar Partida, Charles Laurin, Susan M Ring, Tom R Gaunt, Allan F McRae, Peter M Visscher, Grant W Montgomery, Nicholas G Martin, Gibran Hemani, Matthew Suderman, Caroline L Relton, George Davey Smith, and David M Evans. Genome-wide survey of parent-of-origin effects on dna methylation identifies candidate imprinted loci in humans. Human Molecular Genetics, 27(16):2927â€“2939, June 2018. URL: http://dx.doi.org/10.1093/hmg/ddy206, doi:10.1093/hmg/ddy206. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddy206)

[3. (Xia2020Hepatic) Chengdong Xia, Xiuli Zhang, Tianshu Cao, Jiannong Wang, Cuidan Li, Liya Yue, Kaifeng Niu, Yicheng Shen, Guannan Ma, and Fei Chen. Hepatic transcriptome analysis revealing the molecular pathogenesis of type 2 diabetes mellitus in zucker diabetic fatty rats. Frontiers in Endocrinology, November 2020. URL: http://dx.doi.org/10.3389/fendo.2020.565858, doi:10.3389/fendo.2020.565858. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2020.565858)